Alto Neuroscience, Inc. (ANRO) — Stock Score Summary

Alto Neuroscience, Inc. (ANRO) has a MoatMap StockRank of 52/100 based on Quality (38/100), Value (38/100), and Momentum (62/100) factor scores. The current signal is HOLD. Alto Neuroscience is a clinical-stage biotech focused on precision psychiatry. It is pre-revenue and faces binary clinical trial risks, failing our core quality and cash-flow requirements.

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company pioneering precision psychiatry through its proprietary Precision Psychiatry Platform. The company's competitive moat is built on its AI-driven analysis of brain biomarkers, EEG, and behavioral data to match patients with targeted drug candidates. It operates as a niche innovator aiming to revolutionize treatment for depression and other mental health conditions.

Key Financial Metrics

Price$21.15
Market Cap$710M
P/E (Forward)-5.83
Price/Book2.88
Return on Equity-38.9%
Return on Invested Capital-35.1%
Debt/Equity9.00
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-40M

Alto Neuroscience, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Alto Neuroscience, Inc.’s (ANRO) StockRank?
MoatMap’s StockRank for Alto Neuroscience, Inc. (ANRO) is 52/100, with a Hold signal. It is a composite of Quality (38), Value (38), and Momentum (62) factor ranks across MoatMap’s 19,000+ stock universe.
Does Alto Neuroscience, Inc. have an economic moat?
Alto Neuroscience, Inc. (ANRO) has a Quality factor score of 38/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Alto Neuroscience, Inc. a buy, hold, or sell?
MoatMap’s current signal for Alto Neuroscience, Inc. (ANRO) is Hold, based on a StockRank of 52/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Alto Neuroscience, Inc. in?
Alto Neuroscience, Inc. (ANRO) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksANRO deep dive reportAI ChampionsHow we score stocksSense-check another stock